AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks | Fierce Biotech
August 26, 2022: AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks | Fierce Biotech
Entries by Bhushan Sreekrishnavilas
Guide dog etiquette – Wairarapa Times-Age
August 22, 2022: Guide dog etiquette – Wairarapa Times-Age
Diversity in Diabetes Clinical Trials
August 19, 2022: Diversity in Diabetes Clinical Trials
Opinion: Awareness-raising is key to deliver eye health for all by 2030 | Devex
August 15, 2022: Opinion: Awareness-raising is key to deliver eye health for all by 2030 | Devex
Gene therapy: Where the action is for retinal diseases
August 11, 2022: Gene therapy: Where the action is for retinal diseases
Diabetic Ketoacidosis
August 2, 2022: Diabetic Ketoacidosis
Testosterone therapy improves quality of life in men with hypogonadism, type 2 diabetes
August 1, 2022: Testosterone therapy improves quality of life in men with hypogonadism, type 2 diabetes
Proteins in liquor could provide information about inflammatory processes in the brain
July 26, 2022: Proteins in liquor could provide information about inflammatory processes in the brain
Glaucoma stem cell research could help develop new drugs to combat disease
July 21, 2022: Glaucoma stem cell research could help develop new drugs to combat disease
Oregon State research reveals how key diabetes drug is made in nature
July 19, 2022: Oregon State research reveals how key diabetes drug is made in nature
You must be logged in to post a comment.